CLINICAL_TRIALS
trial_result
· 2011-01-27
Clinical Trial Update: Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis [Phase 3]
Summary
A completed Phase 3 dose-finding trial compared 200 mg vs 400 mg daily doses of quetiapine fumarate in first-episode psychosis to determine the optimal dosing.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Psychosis | Phase 3 | Status: COMPLETED